STOCKWATCH
·
Pharmaceuticals
Quarterly Result2 Aug 2025, 02:16 pm

Shree Ganesh Remedies Limited Reports Q1FY26 Results: Revenue Down by 0.45% YoY

AI Summary

Shree Ganesh Remedies Limited, a leading player in the chemical manufacturing industry, announced its financial results for Q1FY26. The company reported a moderate growth, with revenue from operations at 24.67 crore, a slight decrease of 0.45% YoY. The EBITDA margins also saw a decrease of 321 bps YoY, now representing a more normalised and sustainable level. The company is optimistic about the future, with multiple new projects in the pipeline and a new pilot facility being established. The focus for FY26 is on building necessary infrastructure to support a significant scale-up.

Key Highlights

  • Revenue from operations down by 0.45% YoY
  • EBITDA margins decreased by 321 bps YoY
  • Multiple new projects in the pipeline
  • Establishing a new pilot facility
  • Focus on building necessary infrastructure for scale-up
SGRL
Pharmaceuticals
Shree Ganesh Remedies Ltd

Price Impact